In another AD examining skin from patients receiving dupilumab treatment (IL4RA blocking antibody), scRNAseq revealed that LAMP3+IL15+ DCs remained in the tissue alongside T cells after treatment, suggesting that these populations may contribute to disease recurrence [42]. The gene discussed is LAMP3; the disease is Alzheimer disease.